SMAB Emeritus Member Becomes Surgical Chair
The Cholangiocarcinoma Foundation is pleased to share that Dr. Cristina R. Ferrone, one of the Foundation’s esteemed Science and Medical Advisory Board emeritus members, has been appointed as the new chair of surgery at Cedars-Sinai. This significant achievement not only marks a historic moment as she becomes the first female chair of surgery at Cedars-Sinai but also elevates the profile and importance of cholangiocarcinoma within the medical community.
Dr. Ferrone’s impressive academic and professional journey includes graduating from the University of Pennsylvania, earning her medical degree from Washington University School of Medicine in St. Louis, completing a general surgery residency at Massachusetts General Hospital, and a surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. She also holds a master’s degree in clinical trial design from the Harvard/MIT Investigator Training Program.
With a focus on pancreas, liver, and bile duct cancer, both clinically and in her research lab, Dr. Ferrone is currently leading the largest pancreatic cancer trial in North America. Her dedication to surgical oncology and her collaborative approach to patient care resonate deeply with the Cholangiocarcinoma Foundation’s mission.
CCF Founder and CEO, Stacie Lindsey, shared “Dr. Ferrone’s appointment as chair of surgery at Cedars-Sinai is a testament to her exceptional skills and dedication. Her contributions to the field of surgical oncology are invaluable, and her new role significantly elevates the visibility and importance of cholangiocarcinoma within the medical community. We are honored to have her as a part of our scientific community.”
Dr. Ferrone’s belief in collaboration and multidisciplinary approaches in cancer treatment is crucial in advancing understanding and treatment of cancer. Her commitment to patient care, research, and education continues to inspire and drive progress in the field.
Dr. Ferrone’s appointment as chair of surgery at Cedars-Sinai is a testament to her exceptional skills and dedication. Her contributions to the field of surgical oncology are invaluable, and her new role significantly elevates the visibility and importance of cholangiocarcinoma within the medical community. We are honored to have her as a part of our scientific community.
Stacie Lindsey, CCF Founder & CEO
Please join us in congratulating Dr. Ferrone on her new position and celebrating her ongoing contributions to advancing patient care. Her dedication and expertise are instrumental in CCF’s efforts to find a cure and improve the quality of life for those affected by cholangiocarcinoma.